Atlas Trials

Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed

RecordFirmDate
Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial. (NCT06133088)Zhejiang Cancer Hospital2023-08-01

Track Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed automatically

Every clearance here is in the API, with alerts when new ones post.